Answer
It is unknown whether vadadustat passes into human breast milk; risk to the breastfed infant cannot be excluded, and a decision about stopping breast-feeding or Vafseo therapy must consider the benefits to the child and woman.
Sources for this answer
- Vafseo 300 mg film-coated tabletsMedice UK LTD · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked